newsio aggregates and links to original sources. We do not own the original images or content. If you believe content infringes on intellectual property rights, contact us — it will be removed at first notice.

business / news / / Devdiscourse

Powder supplement brand AG1 is exploring a sale option involving the whole company.

C4 Therapeutics and Roche signed a $1 billion deal for degrader-antibody conjugate cancer drugs.

KEY POINTS
COMPANIES
Read the full story on Devdiscourse →
Share X LinkedIn

Summarized by Newsio from Devdiscourse. How we summarize →